✦ LIBER ✦

Re: Phase II Trial of Sorafenib Plus Interferon Alfa-2b as First- or Second-Line Therapy in Patients with Metastatic Renal Cell Cancer

✍ Scribed by Fray F. Marshall

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase II trial of capecitabine plus cisp

✍ Daniel T. T. Chua; Harry Ho-Yin Yiu; Kasan Seetalarom; Alice Wan-Ying Ng; Johan 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 175 KB

Phase II trial of combination interferon

✍ Peter E. Clark; M.Craig Hall; Antonius Miller; Kevin P. Ridenhour; Diana Stindt; 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 114 KB

795 ORAL Phase II trial of sorafenib (BA

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 273 KB

Phase II Trial of Pyrazoloacridine as Se

✍ Paul M. Dodd; John A. McCaffrey; Madhu Mazumdar; Evelyn Icasiano; Geralyn Higgin 📂 Article 📅 2000 🏛 Springer US 🌐 English ⚖ 50 KB

An Open-label, Single-arm, Phase 2 Trial

✍ Allen L. Cohn; Grace C. Shumaker; Pankaj Khandelwal; David A. Smith; Marcus A. N 📂 Article 📅 2011 🏛 CIG Media Group, LP. 🌐 English ⚖ 429 KB

A multi-center phase II study of docetax

✍ Jin Young Kim; Young Rok Do; Keon Uk Park; Min Kyung Kim; Kyung Hee Lee; Sung Hw 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 200 KB